{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:16:59Z","timestamp":1789064219535,"version":"build-2803163510"},"reference-count":9,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,12,18]]},"abstract":"<jats:p>Drug-induced acute pancreatitis (DIAP) is a rare, but clinically significant diagnosis. Vedolizumab, an \u03b1<jats:sub>4<\/jats:sub>\u03b2<jats:sub>7<\/jats:sub> integrin inhibitor, which was approved in 2015 for treatment of moderate to severe inflammatory bowel disease, is a well-tolerated medication with a favourable safety profile and minimal serious adverse events in premarketing clinical trials. We present the first reported case of acute pancreatitis directly attributable to vedolizumab.<\/jats:p>","DOI":"10.1136\/bcr-2017-222554","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T08:46:01Z","timestamp":1515141961000},"page":"bcr-2017-222554","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Vedolizumab-induced acute pancreatitis: the first reported clinical case"],"prefix":"10.1136","volume":"2018","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5013-956X","authenticated-orcid":false,"given":"Sherman","family":"Picardo","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"So","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.1","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v5.i4.405"},{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831100-00002"},{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215734"},{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215739"},{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60107-5"},{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2016.236","article-title":"The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn\u2019s disease: results from the US Victory Consortium","volume":"111","author":"Dulai","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.7","doi-asserted-by":"publisher","DOI":"10.5223\/pghn.2012.15.4.272"},{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04287.x"},{"key":"2025082700475072000_2018.jan05_1.bcr-2017-222554.9","first-page":"136","article-title":"Crohn\u2019s disease and acute pancreatitis. A review of literature","volume":"16","author":"Jasdanwala","year":"2015","journal-title":"JOP"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-222554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:47:59Z","timestamp":1756280879000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-222554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":9,"alternative-id":["10.1136\/bcr-2017-222554"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-222554","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}